Abstract
s / Can J Diabetes 39 (2015) 529e547 537 insight in to pathogenesis of T1DM and the mechanism of the honeymoon phase. 029-2015. CLINICAL CARE Triple Metabolic Therapy in Patients with Advanced Malignancy DAVID MORRIS*y
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
